Citations

Showing 10 of 108083 citations.

Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T)
Nicolosi, Maura , Mudireddy, Mythri , Vallapureddy, Rangit, Gangat, Naseema , Tefferi, Ayalew , Patnaik, Mrinal M.

Mayo Clinic

American Journal of Hematology | October 25, 2017 | Volume: 93 | Issue: 1 | Pages: No page available

10.1002/ajh.24952 | PMID 29067707 Get It

Phosphate Functional Groups Improve Oligo[(Polyethylene Glycol) Fumarate] Osteoconduction and BMP-2 Osteoinductive Efficacy
Olthof, Maurits G.L. , Tryfonidou, Marianna A. , Liu, Xifeng , Pouran, Behdad , Meij, Björn P. , Dhert, Wouter J.A. , Yaszemski, Michael J. , Lu, Lichun , Alblas, Jacqueline , Kempen, Diederik H.R.

Mayo Clinic

Tissue Engineering Part A | October 25, 2017 | Volume: 24 | Issue: 9-10 | Pages: 819-829

10.1089/ten.tea.2017.0229 | PMID 29065776 Get It

Demographic and epidemiologic characterization of transfusion recipients from four US regions: evidence from the REDS‐III recipient database
Karafin, Matthew S. , Bruhn, Roberta , Westlake, Matt , Sullivan, Mark , Bialkowski, Walter , Edgren, Gustaf , Kor, Daryl J. , Fleischmann, Debra, Gottschall, Jerome L. , Murphy, Edward L. , Triulzi, Darrell J., Roubinian, Nareg H. , Hauser, Ronald George

Mayo Clinic

Transfusion | October 25, 2017 | Volume: 57 | Issue: 12 | Pages: 2903-2913

10.1111/trf.14370 | PMID 29067705 Get It

BACKGROUNDBlood transfusion is one of the most common medical procedures during hospitalization in the United States. To understand the benefits of transfusion while mitigating potential risks, a multicenter database containing detailed information on transfusion incidence and recipient outcomes would facilitate research.STUDY DESIGN AND METHODSThe Recipient Epidemiology and Donor Evaluation Study‐III (REDS‐III) program has developed a comprehensive transfusion recipient database utilizing data from hospital electronic health records at 12 participating hospitals in four geographic regions. Inpatient and outpatient data on transfusion recipients from January 1, 2013 to December 31, 2014 included patient age, sex, ethnicity, primary diagnosis, type of blood product provided, issue location, pretransfusion and post‐transfusion hemoglobin (Hgb), and hospital outcomes. Transfusion incidence per encounter was calculated by blood product and various patient characteristics.RESULTSDuring the 2‐year study period, 80,362 (12.5%) inpatient encounters involved transfusion. Among inpatients, the most commonly transfused blood products were red blood cells (RBCs; 10.9% of encounters), followed by platelets (3.2%) and plasma (2.9%). Among patients who received transfusions, the median number of RBC units was one, the pretransfusion Hgb level was 7.6 g/dL, and the Hgb increment per unit was 1.4 g/dL. Encounter mortality increased with patient age, the number of units transfused, and the use of platelet or plasma products. The most commonly reported transfusion reaction was febrile nonhemolytic.CONCLUSIONThe database contains comprehensive data regarding transfusion use and patient outcomes. The current report describes an evaluation of the first 2 years of a planned, 4‐year, linked blood donor‐component‐recipient database, which represents a critical new resource for transfusion medicine researchers.
Development and Feasibility of a Home Pulmonary Rehabilitation Program With Health Coaching
Benzo, Roberto P. , Kramer, K. , Hoult, Johanna, Anderson, Paige M , Begue, Ivonne M, Seifert, Sara J.

Mayo Clinic

Respiratory Care | October 24, 2017 | Volume: 63 | Issue: 2 | Pages: 131-140

10.4187/respcare.05690 | PMID 29066590 Get It

BACKGROUND: Pulmonary rehabilitation (PR) is an effective intervention for COPD. However, traditional center-based PR programs suffer from low uptake. Home-based PR is a viable solution, but few studies have shown the effectiveness of remote PR, as there is a scarcity of systems that can be easily adopted in clinical practice. The aim of this report is to communicate the development and feasibility of a home PR program that includes commercially available technology that allows the PR health coach to follow the patient through his or her PR process and to present the design of a prospective clinical trial. METHODS: We developed a home PR system that includes a computer tablet, an activity monitor, and an oximeter connected to a cloud server. The home PR consists of 12 min of walking and 6 full-body exercises, to be completed 6 d/week, plus weekly telephone calls with the PR health coach. Two pilot studies were conducted in subjects with moderate-to-severe COPD. The first aimed to fine-tune the system development ( N = 3), and the second tested the program feasibility of the 8-week program ( N = 12). RESULTS: In pilot study 1, PR monitoring data from the subjects' home PR sessions were transmitted to the health coach application successfully. On a 10-point scale, participants rated the system as helpful (median = 8, interquartile range 8–9) and simple to use (median = 10, interquartile range 9–10). In pilot study 2, adherence ± SD for prescribed use was 87 ± 0.24%. Overall, participants gave the home PR system a rating of 6.2 ± 0.94 on a 7-point scale. CONCLUSIONS: A home PR program was developed that integrated health coaching and a home PR system that facilitated remote monitoring. Pilot testing indicated that the program is well-developed and feasible in a population of individuals with COPD. (ClinicalTrials.gov registration NCT02999685.)
OCULAR MANIFESTATIONS OF SYSTEMIC AMYLOIDOSIS
Reynolds, Margaret , Veverka, Kevin K. , Zeldenrust, Steven R., Pulido, José S. , Reynolds, Margaret M, Reynolds, Margaret M , Gertz, Morie A. , Dispenzieri, Angela , Leung, Nelson

Mayo Clinic

Retina | October 24, 2017 | Volume: 38 | Issue: 7 | Pages: 1371-1376

10.1097/iae.0000000000001901 | PMID 29068915 Get It

Purpose: To describe ophthalmic manifestations of systemic amyloidosis, a group of devastating conditions. Methods: A retrospective chart review including patients who had ocular examinations at Mayo Clinic between January 1, 1985, and April 1, 2014, and a diagnosis of light-chain (AL), secondary (AA), or nontransthyretin familial amyloidosis was undertaken. Sixty-eight patients with AL amyloidosis, eight patients with AA amyloidosis, and five patients with nontransthyretin familial amyloidosis were included. Results: Of 68 patients, 8 patients (14 eyes) with AL amyloidosis had ocular involvement secondary to conjunctiva, temporal artery, extraocular muscle, trabecular meshwork, and cranial nerve deposition. One of the five patients with nontransthyretin familial amyloidosis had gelsolin-related corneal dystrophy. No patients with AA amyloidosis (n = 8) had ophthalmic manifestations. Conclusion: Systemic amyloidosis can lead to ocular morbidity. Patients with AL amyloidosis had involvement of the temporal artery, conjunctiva, extraocular muscles, trabecular meshwork, and cranial nerves. Those with gelsolin nontransthyretin familial amyloidosis were susceptible to corneal dystrophy. Patients with AA amyloidosis did not manifest ophthalmic involvement. Finally, if ocular amyloidosis is detected, patients should be referred for systemic workup.
The Future of Contrast-Enhanced Mammography
Pizzitola, Victor J. , Lorans, Roxanne, Pockaj, Barbara A. , Northfelt, Donald W. , Appleton, Catherine M. , Patel, Bhavika , Covington, Matthew F, Patel, Bhavika K , Covington, Matthew F.

Mayo Clinic

American Journal of Roentgenology | October 24, 2017 | Volume: 210 | Issue: 2 | Pages: 292-300

10.2214/ajr.17.18749 | PMID 29064748 Get It

Variability of Postsurgical Imaging Surveillance of Breast Cancer Patients: A Nationwide Survey Study
Patel, Bhavika , Lee, Cindy , Newell, Mary S. , Pizzitola, Victor J. , D’Orsi, Carl J., Patel, Bhavika K , Kosiorek, Heidi

Mayo Clinic

American Journal of Roentgenology | October 24, 2017 | Volume: 210 | Issue: 1 | Pages: 222-227

10.2214/ajr.17.17923 | PMID 29064749 Get It

Multicenter Analysis of Midterm Clinical Outcomes of Arthroscopic Labral Repair in the Hip: Minimum 5-Year Follow-up
Krych, Aaron J. , Johnson, Nick R., Redmond, John M., Hartigan, David E. , Levy, Bruce A. , Domb, Benjamin G. , Krych, Aaron J , Hevesi, Mario

Mayo Clinic

The American Journal of Sports Medicine | October 24, 2017 | Volume: 46 | Issue: 2 | Pages: 280-287

10.1177/0363546517734180 | PMID 29065275 Get It

Background: The technique of hip arthroscopic surgery is advancing and becoming more commonly performed. However, most current reported results are limited to short-term follow-up, and therefore, the durability of the procedure is largely unknown. Purpose: To perform a multicenter analysis of mid-term clinical outcomes of arthroscopic hip labral repair and determine the risk factors for patient outcomes. Study Design: Cohort study; Level of evidence, 3. Methods: Prospectively collected data of primary hip arthroscopic labral repair performed at 4 high-volume centers between 2008 and 2011 were reviewed retrospectively. Patients were assessed preoperatively and postoperatively with the visual analog scale (VAS), modified Harris Hip Score (mHHS), and Hip Outcome Score–Sports-Specific Subscale (HOS-SSS) at a minimum of 5 years’ follow-up. Factors including age, body mass index (BMI), Tönnis grade, and cartilage grade were analyzed in relation to outcome scores, and revision rates were determined. Failure was defined as subsequent ipsilateral hip surgery, including revision arthroscopic surgery and open hip surgery. Results: A total of 303 patients (101 male, 202 female) with a mean age of 32.0 years (range, 10.7-58.9 years) were followed for a mean of 5.7 years (range, 5.0-7.9 years). Patients achieved mean improvements in VAS of 3.5 points, mHHS of 20.1 points, and HOS-SSS of 29.3 points. Thirty-seven patients (12.2%) underwent revision arthroscopic surgery, and 12 (4.0%) underwent periacetabular osteotomy, resurfacing, or total hip arthroplasty during the study period. Patients with a BMI >30 kg/m 2 had a mean mHHS score 9.5 points lower and a mean HOS-SSS score 15.9 points lower than those with a BMI ≤30 kg/m 2 ( P < .01). Patients aged >35 years at surgery had a mean mHHS score 4.5 points lower and a HOS-SSS score 6.7 points lower than those aged ≤35 years ( P = .03). Patients with Tönnis grade 2 radiographs demonstrated a 12.5-point worse mHHS score ( P = .02) and a 23.0-point worse HOS-SSS score ( P < .01) when compared with patients with Tönnis grade 0. Conclusion: Patients demonstrated significant improvements in VAS, mHHS, and HOS-SSS scores after arthroscopic labral repair. However, those with Tönnis grade 2 changes preoperatively, BMI >30 kg/m 2 , and age >35 years at the time of surgery demonstrated significantly decreased mHHS and HOS-SSS scores at final follow-up.
How to Catch Unicorns (and Other Fairytales)
Brull, Sorin J. , Naguib, Mohamed , Brull, Sorin J

Mayo Clinic

Anesthesiology | October 24, 2017 | Volume: 128 | Issue: 1 | Pages: 1-3

10.1097/aln.0000000000001959 | PMID 29068828 Get It